Office of Drug Evaluation II (ODE II)
Our Mission - The Office of Drug Evaluation II is responsible for protecting the public health by assuring safe and effective drugs and biologics are available to the U.S. population for addiction, allergy, analgesia, anesthesia, diabetes, endocrine, metabolism, pulmonary, and rheumatological conditions.
Director: Mary T. Thanh Hai, M.D. (acting)
Deputy Director: Mary T. Thanh Hai, M.D.
Associate Director for Regulatory Affairs: Sara Stradley
Associate Director for Regulatory Science: Silvana Borges M.D.
Lead Management Officer: Thomas Cunningham
Regulatory Information Specialist: Velma Cunningham
Regulatory Information Specialist: Misbah Baig
- Division of Anesthesia, Analgesia, and Addiction Products (DAAAP)
- Division of Metabolism and Endocrinology Products (DMEP)
- Division of Pulmonary, Allergy, and Rheumatology Products( DPARP)
Office of Drug Evaluation II
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2310
Fax: (301) 796-9717